DEFIANCE NASDAQ JUNIOR BIOTECHNOLOGIESLOGY ETF

DEFIANCE NASDAQ JUNIOR BIOTECHNOLOGIESLOGY ETF

ETF · US26922A1491 · IBBJ (XNAS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of DEFIANCE NASDAQ JUNIOR BIOTECHNOLOGIESLOGY ETF
No Price
Share Float & Liquidity
Free Float -
Shares Float -
Shares Outstanding 275.382,00
Asset Allocation
AssetPercentage %
Stock US90,52 %
Stock non-US9,18 %
Cash0,30 %
NotClassified0,00 %
Other0,00 %
Bond0,00 %
Largest Positions
SymbolISINNamePercentage %
NTLAIntellia Therapeutics Inc 3,25 %
FATEFate Therapeutics Inc 2,66 %
ZLABZai Lab Limited 2,64 %
BBIOBridgeBio Pharma Inc 2,33 %
MEDPMedpace Holdings Inc 2,10 %
BEAMBeam Therapeutics Inc 2,02 %
VIRVir Biotechnology Inc 1,94 %
HALOHalozyme Therapeutics Inc 1,81 %
PACBPacific Biosciences of California Inc 1,69 %
APLSApellis Pharmaceuticals Inc 1,61 %
Region Distribution
RegionPercentage %
North America92,09 %
Asia Emerging3,25 %
Europe Developed2,95 %
Asia Developed0,78 %
United Kingdom0,50 %
Africa/Middle East0,43 %
Australasia0,00 %
Europe Emerging0,00 %
Japan0,00 %
Latin America0,00 %
Sector Distribution
SectorPercentage %
Gesundheitswesen100,00 %
Grundstoffe0,00 %
Verbrauchsgüter0,00 %
Finanzdienstleistungen0,00 %
Immobilien0,00 %
Telekommunikation0,00 %
Energie0,00 %
Industrieunternehmen0,00 %
Technologie0,00 %
Basiskonsumgüter0,00 %
Company Profile for DEFIANCE NASDAQ JUNIOR BIOTECHNOLOGIESLOGY ETF ETF
The investment seeks to track the total return performance, before fees and expenses, of the NASDAQ Junior Biotechnology Index. The index is a rules-based index that consists of a portfolio of the stock of U.S.-listed small capitalization ("junior") companies screened from the universe of the NASDAQ Biotechnology Index. The fund will generally use a "replication" strategy to achieve its investment objective, meaning it will generally invest in all of the component securities of the index in the same approximate proportions as in the index. The fund is non-diversified.
Fund Master Data
Issuer Defiance
Asset Class ETF
Name Defiance Nasdaq Junior Biotechnology ETF
Fund Currency USD
Category Health
Fund Key Figures
Fund Size 8.242,21 EUR
Investment Strategy
The investment seeks to track the total return performance, before fees and expenses, of the NASDAQ Junior Biotechnology Index. The index is a rules-based index that consists of a portfolio of the stock of U.S.-listed small capitalization (junior) companies screened from the universe of the NASDAQ Biotechnology Index. The fund will generally use a replication strategy to achieve its investment objective, meaning it will generally invest in all of the component securities of the index in the same approximate proportions as in the index. The fund is non-diversified.

Company Data

Name DEFIANCE NASDAQ JUNIOR BIOTECHNOLOGIESLOGY ETF
Company Defiance Nasdaq Junior Biotechnology ETF
Symbol IBBJ
Primary Exchange XNAS NASDAQ
ISIN US26922A1491
Asset Class ETF
Sector Financial Services
Industry Asset Management
Country United States of America
Currency USD
Employees -
IPO Date 2020-08-03
Dividends from 'DEFIANCE NASDAQ JUNIOR BIOTECHNOLOGIESLOGY ETF'
Ex-Date Dividend per Share
29.12.2020 0,30 USD

Ticker Symbols

Name Symbol
NASDAQ IBBJ
More Shares
Investors who hold DEFIANCE NASDAQ JUNIOR BIOTECHNOLOGIESLOGY ETF also have the following shares in their portfolio:
INTEKPLUS Co., Ltd.
INTEKPLUS Co., Ltd. Share
UNITY SOFTWA 25/30 ZO CV
UNITY SOFTWA 25/30 ZO CV Bond